Similar articles for PMID: 9541290

Year	Number of Results
1982	1
1987	1
1988	2
1991	3
1994	2
1995	1
1996	1
1997	2
1998	8
1999	4
2000	2
2001	8
2002	8
2003	12
2004	6
2005	3
2006	2
2007	5
2008	1
2009	1
2010	5
2011	3
2012	4
2013	1
2014	2
2015	2
2016	1
2017	5
2018	6
2019	2
2020	1
2021	1
2022	0

1

Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Ricci PE, et al. AJNR Am J Neuroradiol. 1998 Mar;19(3):407-13. AJNR Am J Neuroradiol. 1998. PMID: 9541290 Free PMC article.

2

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.

Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Nishikawa M, Ohata K, Torii K, Morino M, Nishio A, Hara M. Tsuyuguchi N, et al. Ann Nucl Med. 2004 Jun;18(4):291-6. doi: 10.1007/BF02984466. Ann Nucl Med. 2004. PMID: 15359921 Clinical Trial.

3

Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?

Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S, Ohata K, Goto T, Hara M. Tsuyuguchi N, et al. J Neurosurg. 2003 May;98(5):1056-64. doi: 10.3171/jns.2003.98.5.1056. J Neurosurg. 2003. PMID: 12744366

4

Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis.

Travers S, Joshi K, Miller DC, Singh A, Nada A, Biedermann G, Cousins JP, Litofsky NS. Travers S, et al. World Neurosurg. 2021 Jul;151:e1059-e1068. doi: 10.1016/j.wneu.2021.05.064. Epub 2021 May 27. World Neurosurg. 2021. PMID: 34052453

5

Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma.

Enslow MS, Zollinger LV, Morton KA, Butterfield RI, Kadrmas DJ, Christian PE, Boucher KM, Heilbrun ME, Jensen RL, Hoffman JM. Enslow MS, et al. Clin Nucl Med. 2012 Sep;37(9):854-61. doi: 10.1097/RLU.0b013e318262c76a. Clin Nucl Med. 2012. PMID: 22889774 Free PMC article. Clinical Trial.

6

Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.

Li H, Deng L, Bai HX, Sun J, Cao Y, Tao Y, States LJ, Farwell MD, Zhang P, Xiao B, Yang L. Li H, et al. AJNR Am J Neuroradiol. 2018 Feb;39(2):280-288. doi: 10.3174/ajnr.A5472. Epub 2017 Dec 14. AJNR Am J Neuroradiol. 2018. PMID: 29242363 Free PMC article.

7

PET imaging for differentiating recurrent brain tumor from radiation necrosis.

Hustinx R, Pourdehnad M, Kaschten B, Alavi A. Hustinx R, et al. Radiol Clin North Am. 2005 Jan;43(1):35-47. doi: 10.1016/j.rcl.2004.09.009. Radiol Clin North Am. 2005. PMID: 15693646 Review.

8

Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.

Xiangsong Z, Weian C. Xiangsong Z, et al. J Neurooncol. 2007 May;82(3):305-11. doi: 10.1007/s11060-006-9286-y. Epub 2006 Nov 22. J Neurooncol. 2007. PMID: 17120157

9

Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.

Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT. Kahn D, et al. AJR Am J Roentgenol. 1994 Dec;163(6):1459-65. doi: 10.2214/ajr.163.6.7992747. AJR Am J Roentgenol. 1994. PMID: 7992747

10

Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.

Stokkel M, Stevens H, Taphoorn M, Van Rijk P. Stokkel M, et al. Nucl Med Commun. 1999 May;20(5):411-7. Nucl Med Commun. 1999. PMID: 10404525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed